Goodman LS , Gilman A . The Pharmacological Basis of Therapeutics, 2nd edition, Macmillan: New York ,1954 pp. 1167–1173.
2.
Slim W.Defeat into Victory. William Clowes and Sons: London , 1956.
3.
Weina PJ . From Atabrine in World War II to Mefloquine in Somalia: the role of education in preventive medicine . Military Med1998; 163: 635–639 .
4.
Page F.Treatment of lupus erythematosus with mepacrine . Lancet1951; 2: 755–758 .
5.
Wallace DJ . The use of quinacrine (Atabrine) in rheumatic disease, a reexamination . Semin Arthritis Rheum1989; 18: 282–297 .
6.
Tye MJ , White H , Appel B et al. Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine . New Engl J Med1959; 260: 63–66 .
7.
Wallace DJ . Antimalarials. In: DJ Wallace and BH Hahn (Eds), Dubois' Lupus Erythematosus, 5th edition, Williams & Wilkins: Baltimore , 1997, pp. 1117–1140.
8.
Toubi E , Rosner I , Rozenbaum M , Kessel A , Golan AD . The benefit of combining hydroxychloroquine with quinacrine in the treatment of lupus patients . Lupus2000; 9: 1–4 .
9.
Lipsker D , Piette J-C , Cacoub P et al. Chloroquine-quinacrine association in resistant cutaneous lupus . Dermatology1995; 190: 257–258 .
10.
Feldmann R , Salomon D , Saurat JH . The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus . Dermatology1994; 189: 425–427 .
11.
Wallace DJ . Antimalarial agents and lupus . Rheum Dis Clin NA1994; 20: 243–264 .